AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10319784 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine (10 micrograms/kg in 7 ml saline followed by 6 micrograms/kg/h for 12 hours)
Number of subjects: 60
Study 10319784 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (0.5% 7 ml followed by 0.25% 7 ml/h for 12 hours)
Number of subjects: 60
Study 10319784 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (0.25% 7 ml followed by 0.125% 7 ml/h for 12 hours)
Number of subjects: 60
Study 8916485 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy
Number of subjects: 1012
Study 8916485 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty
Number of subjects: 1012
Study 1841829 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunoglobulin preparation (monomeric IgG, 90% concentration), 500 mg per day, subdivided into 5 doses for 65 neonates
Number of subjects: 132
Study 1841829 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 132
Study 6138932 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-adrenergic stimulation
Number of subjects: 0
Study 6138932 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-adrenergic stimulation
Number of subjects: 0
Study 6138932 — intervention group
Group type: COMPARATOR
Intervention: Beta-adrenergic blockade
Number of subjects: 0
Study 6138932 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant alpha-blockade
Number of subjects: 0
Study 31276501 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise training program (2 sessions/day for 5-7 consecutive days)
Number of subjects: 370
Study 28210859 — intervention group
Group type: EXPERIMENTAL
Intervention: Peloid therapy + splint treatment (every night for 6 weeks + five consecutive days a week for 2 weeks)
Number of subjects: 70
Study 28210859 — intervention group
Group type: COMPARATOR
Intervention: Control group (splint treatment alone, every night for 6 weeks)
Number of subjects: 70
Study 27697671 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min computer-guided mindset intervention
Number of subjects: 96
Study 27697671 — intervention group
Group type: COMPARATOR
Intervention: Supportive-therapy control
Number of subjects: 96
Study 24592984 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) plus Cimicifugae racemosae (CR)
Number of subjects: 194
Study 24592984 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 194
Study 21943634 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed 'nondeformable' fundoplication
Number of subjects: 512
Study 21943634 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 512
Study 21943634 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial fundoplication
Number of subjects: 512
Study 21943634 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (MT)
Number of subjects: 512
Study 19124693 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta9-Tetrahydrocannabinol (10 mg)
Number of subjects: 15
Study 19124693 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (600 mg)
Number of subjects: 15
Study 19124693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 17300297 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral intubation
Number of subjects: 62
Study 17300297 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal intubation
Number of subjects: 62
Study 15142103 — intervention group
Group type: EXPERIMENTAL
Intervention: Optocal Plus (small portion size)
Number of subjects: 67
Study 15142103 — intervention group
Group type: EXPERIMENTAL
Intervention: Optocal Plus (medium portion size)
Number of subjects: 67
Study 15142103 — intervention group
Group type: EXPERIMENTAL
Intervention: Optocal Plus (large portion size)
Number of subjects: 67
Study 15142103 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular implant‐retained overdentures
Number of subjects: 67
Study 15142103 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 67
Study 15142103 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 67
Study 15142103 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 67
Study 11104841 — intervention group
Group type: EXPERIMENTAL
Intervention: zolpidem (10 mg)
Number of subjects: 16
Study 11104841 — intervention group
Group type: EXPERIMENTAL
Intervention: triazolam (0.25 mg)
Number of subjects: 16
Study 11104841 — intervention group
Group type: EXPERIMENTAL
Intervention: temazepam (30 mg)
Number of subjects: 16
Study 11104841 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 9100427 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at doses of 5 mg, 10 mg, 15 mg, and 20 mg
Number of subjects: 76
Study 9100427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 9100427 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 76
Study 8469621 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg 3 times/day
Number of subjects: 25
Study 8469621 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 650 mg 3 times/day
Number of subjects: 25
Study 8469621 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 650 mg 3 times/day
Number of subjects: 25
Study 3086261 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose-restricted diet
Number of subjects: 64
Study 3086261 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactase group (milk with lactase enzyme)
Number of subjects: 64
Study 3086261 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular diet with milk)
Number of subjects: 64
Study 3219992 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug information sheets issued
Number of subjects: 107
Study 3219992 — intervention group
Group type: COMPARATOR
Intervention: No drug information sheets issued
Number of subjects: 107
Study 30755470 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy dietary pattern
Number of subjects: 320
Study 30755470 — intervention group
Group type: COMPARATOR
Intervention: Healthy dietary pattern
Number of subjects: 320
Study 30755470 — intervention group
Group type: COMPARATOR
Intervention: Traditional dietary pattern
Number of subjects: 320
Study 29432399 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 92
Study 29432399 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation
Number of subjects: 92
Study 29122787 — intervention group
Group type: EXPERIMENTAL
Intervention: Octenidine-impregnated wash mitts
Number of subjects: 225000
Study 29122787 — intervention group
Group type: COMPARATOR
Intervention: Placebo wash mitts
Number of subjects: 225000
Study 26630143 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 6068
Study 26630143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6068
Study 23360122 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated analysis of colonic manometry data
Number of subjects: 17
Study 23360122 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 17
Study 23360122 — intervention group
Group type: COMPARATOR
Intervention: Comparison between patients and controls
Number of subjects: 17
Study 21146881 — intervention group
Group type: COMPARATOR
Intervention: Bedtime NPH
Number of subjects: 85
Study 21146881 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime glargine
Number of subjects: 85
Study 21146881 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning glargine
Number of subjects: 85
Study 18617122 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol, 1 mg/kg
Number of subjects: 27
Study 18617122 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol, 0.1 mg/kg
Number of subjects: 27
Study 18617122 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine, 1 mg
Number of subjects: 27
Study 16598373 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium ranelate 2 g/day
Number of subjects: 5082
Study 16598373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5082
Study 12600337 — intervention group
Group type: EXPERIMENTAL
Intervention: First perturbation
Number of subjects: 44
Study 12600337 — intervention group
Group type: EXPERIMENTAL
Intervention: Second perturbation
Number of subjects: 44
Study 10834523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen lysine (10 mg/kg), followed by 5 mg/kg after 24 h and 48 h
Number of subjects: 46
Study 10834523 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 46
Study 10834523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen prophylaxis
Number of subjects: 46
Study 10834523 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin treatment
Number of subjects: 46
Study 10834523 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ligation
Number of subjects: 46
Study 9087158 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine (0.5 mg)
Number of subjects: 20
Study 9087158 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8227846 — intervention group
Group type: COMPARATOR
Intervention: Conventional loading dose of amiodarone (600 mg twice a day for 10 days)
Number of subjects: 32
Study 8227846 — intervention group
Group type: EXPERIMENTAL
Intervention: High loading dose of amiodarone (50 mg/kg per day on days 1-3, 30 mg/kg per day on days 4-5, and 600 mg twice a day on days 6-10)
Number of subjects: 32
Study 3456945 — intervention group
Group type: EXPERIMENTAL
Intervention: 15(R)‐15‐methyl prostaglandin E2 (PGE2)
Number of subjects: 12
Study 3456945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29673374 — intervention group
Group type: EXPERIMENTAL
Intervention: Announcement training
Number of subjects: 83
Study 29673374 — intervention group
Group type: COMPARATOR
Intervention: Conversation training
Number of subjects: 83
Study 28659053 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior approach (group I)
Number of subjects: 68
Study 28659053 — intervention group
Group type: COMPARATOR
Intervention: Anterolateral approach (group II)
Number of subjects: 68
Study 26769839 — intervention group
Group type: EXPERIMENTAL
Intervention: FiO2 1.0 for 60 minutes
Number of subjects: 24
Study 26769839 — intervention group
Group type: COMPARATOR
Intervention: FiO2 0.4 for 60 minutes
Number of subjects: 24
Study 23791232 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early feeding regimen (within 24 hours of birth)
Number of subjects: 60
Study 23791232 — intervention group
Group type: COMPARATOR
Intervention: Delayed feeding regimen (after 24 hours of birth)
Number of subjects: 60
Study 23791232 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early feeding regimen
Number of subjects: 60
Study 23791232 — intervention group
Group type: COMPARATOR
Intervention: Delayed feeding regimen
Number of subjects: 60
Study 23791232 — intervention group
Group type: EXPERIMENTAL
Intervention: Both feeding regimens
Number of subjects: 60
Study 21417807 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation (20 minutes of guided meditation)
Number of subjects: 32
Study 21417807 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation (20 minutes of guided meditation before stress)
Number of subjects: 32
Study 21417807 — intervention group
Group type: COMPARATOR
Intervention: Control (waiting quietly for an equivalent period of meditation time)
Number of subjects: 32
Study 19043153 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-20 mg/day)
Number of subjects: 314
Study 17012527 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (opioid antagonist)
Number of subjects: 18
Study 17012527 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 12680739 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-ketamine (subanaesthetic doses)
Number of subjects: 12
Study 12680739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10853206 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol at subhypnotic dose (1.0 mg/kg/h)
Number of subjects: 60
Study 10853206 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Intralipid)
Number of subjects: 60
Study 9358126 — intervention group
Group type: EXPERIMENTAL
Intervention: Desirudin (15 mg subcutaneously twice daily)
Number of subjects: 2079
Study 9358126 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin (40 mg subcutaneously once daily)
Number of subjects: 2079
Study 9358126 — intervention group
Group type: EXPERIMENTAL
Intervention: Desirudin
Number of subjects: 2079
Study 9358126 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 2079
Study 8415497 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug prevention program with 11 lessons (8 in grade 7 and 3 in grade 8), taught by adult teachers and older teens in some schools.
Number of subjects: 30
Study 8415497 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug prevention program taught by adults without teen leaders.
Number of subjects: 30
Study 8415497 — intervention group
Group type: COMPARATOR
Intervention: All treatment conditions (both groups).
Number of subjects: 30
Study 3463568 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard remission induction treatment
Number of subjects: 738
Study 29952639 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibratory stimulation device (DentalVibe)
Number of subjects: 32
Study 29952639 — intervention group
Group type: COMPARATOR
Intervention: Conventional techniques
Number of subjects: 32
Study 28166840 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐learning with the serious gaming app Touch Surgery (TM) for chest drain insertion
Number of subjects: 90
Study 28166840 — intervention group
Group type: COMPARATOR
Intervention: serious gaming for an unrelated procedure
Number of subjects: 90
Study 26132315 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional surgery
Number of subjects: 224
Study 26132315 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 224
Study 26132315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy (UGFS)
Number of subjects: 224
Study 24080592 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg daily)
Number of subjects: 39
Study 24080592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 20498621 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceuticals (NUTs)
Number of subjects: 1380
Study 20498621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1380
Study 19000554 — intervention group
Group type: EXPERIMENTAL
Intervention: trans-resveratrol (400 mg) after a standard high fat content meal
Number of subjects: 24
Study 19000554 — intervention group
Group type: COMPARATOR
Intervention: trans-resveratrol (400 mg) after 8 hours of fasting
Number of subjects: 24
Study 19000554 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of fed vs fasting conditions for Cmax
Number of subjects: 24
Study 19000554 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of fed vs fasting conditions for AUC0- yen
Number of subjects: 24
Study 16357550 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressively increased high-intensity aerobic exercise (n = 12)
Number of subjects: 22
Study 16357550 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 22
Study 12836810 — intervention group
Group type: EXPERIMENTAL
Intervention: sibutramine 10 mg once a day
Number of subjects: 57
Study 12836810 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 57
Study 11144703 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0
Study 11144703 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 0
Study 11144703 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release/extended-release metoprolol
Number of subjects: 0
Study 11144703 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers (general)
Number of subjects: 0
Study 8909907 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 304
Study 8909907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study 1683929 — intervention group
Group type: EXPERIMENTAL
Intervention: HyperCritic computer program
Number of subjects: 20
Study 1683929 — intervention group
Group type: COMPARATOR
Intervention: Panel of eight physicians
Number of subjects: 20
Study 1683929 — intervention group
Group type: EXPERIMENTAL
Intervention: HyperCritic
Number of subjects: 20
Study 1683929 — intervention group
Group type: COMPARATOR
Intervention: Physician reviewers
Number of subjects: 20
Study 6121181 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) enemas
Number of subjects: 9
Study 6121181 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone enemas
Number of subjects: 9
Study 30661690 — intervention group
Group type: EXPERIMENTAL
Intervention: Yacon flour (25 g daily)
Number of subjects: 26
Study 30661690 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 26
Study 28494116 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating-rotating power toothbrush
Number of subjects: 41
Study 28494116 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 41
Study 25534388 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of androgen suppression (AS) followed by radiotherapy with an additional 8 weeks of concurrent AS (16 weeks total)
Number of subjects: 1579
Study 25534388 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 weeks of androgen suppression (AS) followed by radiotherapy with an additional 8 weeks of AS (36 weeks total)
Number of subjects: 1579
Study 23233383 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI model
Number of subjects: 66
Study 23233383 — intervention group
Group type: EXPERIMENTAL
Intervention: CT model
Number of subjects: 66
Study 23233383 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaging criteria for favorable penumbral pattern
Number of subjects: 66
Study 21805159 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP plus standard treatment
Number of subjects: 207
Study 21805159 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 207
Study 18779759 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 48
Study 18779759 — intervention group
Group type: COMPARATOR
Intervention: Caloric Restriction (CR)
Number of subjects: 48
Study 18779759 — intervention group
Group type: COMPARATOR
Intervention: Caloric Restriction + Resistance Training (CR + RT)
Number of subjects: 48
Study 18779759 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 48
Study 16702494 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone pulse (DP) therapy
Number of subjects: 20
Study 16702494 — intervention group
Group type: COMPARATOR
Intervention: Placebo pulse (PP) therapy
Number of subjects: 20
Study 15611396 — intervention group
Group type: EXPERIMENTAL
Intervention: Butterbur Ze339 high dose (1 tablet 3 times daily)
Number of subjects: 186
Study 15611396 — intervention group
Group type: EXPERIMENTAL
Intervention: Butterbur Ze339 low dose (1 tablet twice daily)
Number of subjects: 186
Study 15611396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study 15611396 — intervention group
Group type: EXPERIMENTAL
Intervention: Butterbur Ze339 (both doses)
Number of subjects: 186
Study 11732835 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified constraint induced therapy (CIT)
Number of subjects: 6
Study 11732835 — intervention group
Group type: COMPARATOR
Intervention: Regular therapy
Number of subjects: 6
Study 11732835 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 6
Study 9129379 — intervention group
Group type: EXPERIMENTAL
Intervention: Group hypnosis
Number of subjects: 30
Study 9129379 — intervention group
Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 30
Study 9129379 — intervention group
Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 30
Study 8678251 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 IU.kg‐1 of heparin before bypass
Number of subjects: 60
Study 8678251 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU.kg‐1 of heparin
Number of subjects: 60
Study 8678251 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 IU.kg‐1 of heparin as bolus followed by a continuous infusion of 10 000 IU.h‐1 until the end of bypass
Number of subjects: 60
Study 8678251 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU.kg‐1 of heparin plus high dose aprotinin (2 million IU of aprotinin before bypass, 500 000 IU.h‐1 until the end of the operation and 2 million IU added to the bypass pump prime)
Number of subjects: 60
Study 8678251 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60
Study 2080791 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous recombinant human erythropoietin (r‐HuEPO)
Number of subjects: 12
Study 2080791 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous recombinant human erythropoietin (r‐HuEPO)
Number of subjects: 12
Study 395958 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatinol O-phosphate (COP)
Number of subjects: 25
Study 395958 — intervention group
Group type: COMPARATOR
Intervention: Reference substance (solvent of COP)
Number of subjects: 25
Study 30728415 — intervention group
Group type: EXPERIMENTAL
Intervention: Buried-knot technique
Number of subjects: 30
Study 30728415 — intervention group
Group type: COMPARATOR
Intervention: Continuous loop technique
Number of subjects: 30
Study 28717899 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians who received no payments ($0)
Number of subjects: 278
Study 28717899 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians who received payments over $13,000
Number of subjects: 278
Study 28717899 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who found their own physician on the website
Number of subjects: 278
Study 28717899 — intervention group
Group type: COMPARATOR
Intervention: Control arm (did not view the disclosure website)
Number of subjects: 278
Study 25829156 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression
Number of subjects: 20